During the past decade, ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" in a lesser frequency.

Most popular intervention types in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ULSS2 Marca Trevigiana; UOC Oncologia Medica - Distretto di Treviso, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".